WITHDRAWAL OF ADALIMUMAB IN EARLY RHEUMATOID ARTHRITIS PATIENTS WHO ATTAINED STABLE LOW DISEASE ACTIVITY WITH ADALIMUMAB PLUS METHOTREXATE: RESULTS OF A PHASE 4, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL

被引：0

作者：

Kavanaugh, Arthur ^{[1
]}

Emery, Paul ^{[2
]}

Fleischmann, Roy ^{[3
]}

van Vollenhoven, Ronald ^{[4
]}

Pavelka, Karel ^{[5
]}

Durez, Patrick ^{[6
]}

Guerette, Benoit ^{[7
]}

Santra, Sourav ^{[8
]}

Redden, Laura ^{[8
]}

Kupper, Hartmut ^{[9
]}

Smolen, Josef S. ^{[10
,11
]}

机构：

[1] Univ Calif San Diego, Div Rheumatol Allergy & Immunol, La Jolla, CA 92093 USA

[2] Leeds Teaching Hosp, Dept Rheumatol, Leeds, W Yorkshire, England

[3] Univ Texas SW Med Ctr Dallas, Dept Rheumatol, Dallas, TX 75390 USA

[4] Karolinska Inst, Dept Rheumatol, Stockholm, Sweden

[5] Charles Univ Prague, Dept Rheumatol, Prague, Czech Republic

[6] Catholic Univ Louvain, Dept Rheumatol, B-1348 Louvain, Belgium

[7] Abbott, GPRD, Rungis, France

[8] Abbott, GPRD, Abbott Pk, IL USA

[9] Abbott, GPRD, Ludwigshafen, Germany

[10] Med Univ Vienna, Dept Rheumatol, Vienna, Austria

[11] Hietzing Hosp, Vienna, Austria

来源：

RHEUMATOLOGY | 2012年 / 51卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：29 / 30

页数：2

共 50 条

[31] Comparison of two strategies of glucocorticoid withdrawal in patients with rheumatoid arthritis in low disease activity (STAR): a randomised, placebo- controlled, double-blind trial
Ruyssen-Witrand, Adeline
Brusq, Clara
Masson, Maeva
Bongard, Vanina
Salliot, Carine
Poiroux, Lucile
Nguyen, Minh
Roux, Christian Hubert
Richez, Christophe
Saraux, Alain
Vergne-Salle, Pascale
Morel, Jacques
Flipo, Rene-Marc
Piperno, Muriel
Gottenberg, Jacques-Eric
Marotte, Hubert
Soubrier, Martin
Gossec, Laure
Dieude, Philippe
Lassoued, Slim
Zabraniecki, Laurent
Couture, Guillaume
Boyer, Jean Frederic
Jamard, Benedicte
Degboe, Yannick
Constantin, Arnaud
ANNALS OF THE RHEUMATIC DISEASES, 2025, 84 (01) : 49 - 59
[32] The Efficacy and Safety of Piclidenoson vs Methotrexate in Early Rheumatoid Arthritis: Phase 3 Randomized, Double-blind, Placebo-controlled Study
Reitblat, Tatiana
Gurman-Balbir, Alexandra
Harpaz, Zivit
Farbstein, Motti
Silverman, Michael
Kerns, William
Fishman, Pnina
ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 3564 - 3566
[33] ADJUVITE: a double-blind, randomised, placebo-controlled trial of adalimumab in early onset, chronic, juvenile idiopathic arthritis-associated anterior uveitis
Quartier, Pierre
Baptiste, Amandine
Despert, Veronique
Allain-Launay, Emma
Kone-Paut, Isabelle
Belot, Alexandre
Kodjikian, Laurent
Monnet, Dominique
Weber, Michel
Elie, Caroline
Bodaghi, Bahram
ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 (07) : 1003 - 1011
[34] Tofacitinib in juvenile idiopathic arthritis: a double-blind, placebo-controlled, withdrawal phase 3 randomised trial
Ruperto, Nicolino
Brunner, Hermine, I
Synoverska, Olga
Ting, Tracy, V
Mendoza, Carlos Abud
Spindler, Alberto
Vyzhga, Yulia
Marzan, Katherine
Grebenkina, Lyudmila
Tirosh, Irit
Imundo, Lisa
Jerath, Rita
Kingsbury, Daniel J.
Sozeri, Betul
Vora, Sheetal S.
Prahalad, Sampath
Zholobova, Elena
Aviel, Yonatan Butbul
Chasnyk, Vyacheslav
Lerman, Melissa
Nanda, Kabita
Schmeling, Heinrike
Tory, Heather
Uziel, Yosef
Viola, Diego O.
Posner, Holly B.
Kanik, Keith S.
Wouters, Ann
Chang, Cheng
Zhang, Richard
Lazariciu, Irina
Hsu, Ming-Ann
Suehiro, Ricardo M.
Martini, Alberto
Lovell, Daniel J.
LANCET, 2021, 398 (10315): : 1984 - 1996
[35] LOW-DOSE METHOTREXATE WITH LEUCOVORIN (FOLINIC ACID) IN THE MANAGEMENT OF RHEUMATOID-ARTHRITIS - RESULTS OF A MULTICENTER RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
SHIROKY, JB
NEVILLE, C
ESDAILE, JM
CHOQUETTE, D
ZUMMER, M
HAZELTINE, M
BYKERK, V
KANJI, M
STPIERRE, A
ROBIDOUX, L
BOURQUE, L
ARTHRITIS AND RHEUMATISM, 1993, 36 (06): : 795 - 803
[36] EFFICACY AND SAFETY OF LEVILIMAB IN COMBINATION WITH METHOTREXATE IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS: 1-YEAR RESULTS OF PHASE III, DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED TRIAL
Mazurov, V.
Korolev, M.
Pristrom, A.
Kundzer, A.
Soroka, N.
Kastanayan, A.
Povarova, T.
Plaksina, T.
Antipova, O.
Kretchikova, D.
Smakotina, S.
Tciupa, O.
Puntus, E.
Raskina, T.
Shilova, L.
Kropotina, T.
Nesmeyanova, O.
Popova, T.
Vinogradova, I.
Linkova, I.
Plotnikova, A.
Pukhtinskaia, P.
Zinkina-Orikhan, A.
Eremeeva, A.
Lutckii, A.
ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 596 - 596
[37] In rheumatoid arthritis patients with stable low disease activity on etanercept plus methotrexate, continuation of etanercept is clinically and radiographically superior to discontinuation: results from a randomized, double-blind clinical trial
Ostergaard, M.
Franck-Larsson, K.
Leirisalo-Repo, M.
Uhlig, T.
Jansson, M.
Larsson, E.
Brock, F.
van Vollenhoven, R.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2014, 43 : 30 - 31
[38] A multicenter, double-blind, randomized, placebo controlled trial of infliximab combined with low dose methotrexate in Japanese patients with rheumatoid arthritis
Abe, T
Takeuchi, T
Miyasaka, N
Hashimoto, H
Kondo, H
Ichikawa, Y
Nagaya, L
JOURNAL OF RHEUMATOLOGY, 2006, 33 (01) : 37 - 44
[39] EFFICACY AND SAFETY OF LEVILIMAB IN COMBINATION WITH METHOTREXATE IN SUBJECTS WITH ACTIVE RHEUMATOID ARTHRITIS: PHASE III, DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED TRIAL
Mazurov, V.
Korolev, M.
Kundzer, A.
Soroka, N.
Kastanayan, A.
Povarova, T.
Plaksina, T.
Antipova, O.
Kretchikova, D.
Smakotina, S.
Tciupa, O.
Raskina, T.
Kropotina, T.
Nesmeyanova, O.
Popova, T.
Dokukina, E.
Plotnikova, A.
Lutskii, A.
Zinkina-Orihan, A.
ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 550 - 551
[40] A Profile of the Efficacy of Sarilumab Plus Methotrexate in Rheumatoid Arthritis Patients: Results of a 52-Week, Phase 3, Randomized, Double-Blind, Placebo-Controlled, International Study.
Kavanaugh, Arthur
Decktor, Dennis L.
Fan, Chunpeng
van Adelsberg, Janet
Martincova, Renata
Genovese, Mark C.
ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S1233 - S1234

← 1 2 3 4 5 →